ATE426014T1 - Probiotisches bakterium: lactobacillus fermentum - Google Patents

Probiotisches bakterium: lactobacillus fermentum

Info

Publication number
ATE426014T1
ATE426014T1 AT03793503T AT03793503T ATE426014T1 AT E426014 T1 ATE426014 T1 AT E426014T1 AT 03793503 T AT03793503 T AT 03793503T AT 03793503 T AT03793503 T AT 03793503T AT E426014 T1 ATE426014 T1 AT E426014T1
Authority
AT
Austria
Prior art keywords
lactobacillus fermentum
probiotic bacteria
disorders
disturbances
variant
Prior art date
Application number
AT03793503T
Other languages
English (en)
Inventor
Paricia Conway
Original Assignee
Probiomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiomics Ltd filed Critical Probiomics Ltd
Application granted granted Critical
Publication of ATE426014T1 publication Critical patent/ATE426014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03793503T 2002-09-06 2003-09-08 Probiotisches bakterium: lactobacillus fermentum ATE426014T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002951270A AU2002951270A0 (en) 2002-09-06 2002-09-06 Probiotic Bacterium and Methods of Use

Publications (1)

Publication Number Publication Date
ATE426014T1 true ATE426014T1 (de) 2009-04-15

Family

ID=27671590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793503T ATE426014T1 (de) 2002-09-06 2003-09-08 Probiotisches bakterium: lactobacillus fermentum

Country Status (14)

Country Link
US (2) US20060067921A1 (de)
EP (1) EP1539927B1 (de)
JP (1) JP4455333B2 (de)
KR (1) KR20050057259A (de)
CN (1) CN100378214C (de)
AT (1) ATE426014T1 (de)
AU (2) AU2002951270A0 (de)
BR (1) BRPI0314060B1 (de)
CA (1) CA2497989C (de)
DE (1) DE60326738D1 (de)
DK (1) DK1539927T3 (de)
ES (1) ES2324532T3 (de)
NZ (1) NZ538640A (de)
WO (1) WO2004022727A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents
WO2005030230A1 (en) * 2003-09-30 2005-04-07 Probiomics Limited Compositions and methods for treatment or prevention of psoriasis and related disorders
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
JP4823503B2 (ja) * 2004-10-14 2011-11-24 ジェンモント バイオテック インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1883393A2 (de) * 2005-05-05 2008-02-06 Lupin Ltd. Stabilisierte orale pharmazeutische zusammensetzungen von cephalosporinen
JP5576606B2 (ja) * 2005-05-18 2014-08-20 ディーエスエム アイピー アセッツ ビー．ブイ． 微生物の腸内投与用組成物
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
CN101657221A (zh) 2006-11-17 2010-02-24 Sca卫生用品公司 包含微生物抑制性组合物的卫生用品
CN109010900A (zh) 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
AU2006350771B2 (en) * 2006-11-17 2012-12-06 Sca Hygiene Products Ab Lactobacillus fermentum Ess-1, DSM17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
WO2008064521A1 (en) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 and use thereof
EP2030623A1 (de) * 2007-08-17 2009-03-04 Nestec S.A. Verhinderung und/oder Behandlung von Stoffwechselerkrankungen durch Modulation der Menge der Enterobakterien
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
JP4903680B2 (ja) * 2007-12-13 2012-03-28 株式会社プロバイオインターナショナル パンの製造方法
FI20080321A0 (fi) * 2008-04-25 2008-04-25 Eino Elias Hakalehto Menetelmä suoliston bakteeritasapainon ylläpitämiseksi
EP2147678A1 (de) * 2008-07-21 2010-01-27 Nestec S.A. Probiotika zur Erhöhung der IgA-Sekretion bei per Kaiserschnitt geborenen Kindern
EP2427499A1 (de) * 2009-05-07 2012-03-14 Tate&Lyle Ingredients France SAS Zusammensetzungen und verfahren zur herstellung von alpha-(1,2)-verzweigten alpha-(1,6)-oligodextranen
AU2010334993B2 (en) * 2009-12-22 2015-07-09 Probi Ab Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
TWI383798B (zh) * 2010-04-27 2013-02-01 Syngen Biotech Co Ltd 改善口腔內細菌群的發酵乳酸桿菌ＳＧ－Ａ９５（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｆｅｒｍｅｎｔｕｍ ＳＧ－Ａ９５）及其保健組合物
HK1253538A1 (en) * 2010-08-04 2019-06-21 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
DE102011001052A1 (de) * 2011-03-03 2012-09-06 Böllhoff Verbindungstechnik GmbH Befestigungseinrichtung mit Toleranzausgleich
KR101378608B1 (ko) * 2011-04-13 2014-03-27 씨제이제일제당 (주) 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주
WO2012162496A1 (en) * 2011-05-24 2012-11-29 Northeastern University Microbial growth factors
JP5928774B2 (ja) * 2011-11-01 2016-06-01 株式会社大阪ソーダ β−１，３−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤
CN103275920B (zh) * 2013-05-16 2015-04-15 江南大学 一种提高乳酸菌粘附肠道上皮细胞能力的方法
KR101452234B1 (ko) * 2013-07-22 2014-10-22 (주) 피엘바이오 장수마을 성인으로부터 분리한 배변활동에 도움을 주는 신규한 유산균 락토바실러스 퍼멘텀
ITMI20131473A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104498383B (zh) * 2014-05-28 2017-12-26 西南大学 一种可调节肠道运动、预防便秘的发酵乳杆菌Lactobacillus fermentum strain suo及其用途
CN104531549B (zh) * 2014-05-28 2018-08-10 西南大学 一种可调节肠道运动、预防便秘的发酵乳杆菌Lactobacillus fermentum strain Zhao及其用途
CN104381440B (zh) * 2014-07-17 2017-07-11 西南民族大学 发酵乳杆菌Lactobacillus fermentum strain Lee工作发酵剂制品及其预防便秘保健用途
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
CN108235682A (zh) * 2015-09-29 2018-06-29 金伯利-克拉克环球有限公司 用于维护微生物群落的健康平衡的协同组合物
KR101937364B1 (ko) * 2016-01-28 2019-01-11 경희대학교 산학협력단 면역조절 작용을 가는 사람 소화관 유래 신규 유산균 및 이의 용도
CA3023867A1 (en) * 2016-05-09 2017-11-16 Biogaia Ab Selection of bacterial strains useful in allergy treatment
IT201600083376A1 (it) 2016-08-08 2018-02-08 Sofar Spa Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it) 2016-06-08 2017-12-08 Sofar Spa Nuovo uso medico di probiotici
TWI598103B (zh) 2016-08-22 2017-09-11 景岳生物科技股份有限公司 改善困難梭狀桿菌感染症狀的發酵乳酸桿菌ｇｍｎｌ－２９６組合物及方法
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
KR102769558B1 (ko) 2017-02-28 2025-02-19 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
CN108450482B (zh) * 2018-03-26 2020-06-12 景岳生物科技股份有限公司 提高抗逆境能力的植物生长调节剂及其用途
CN111248276A (zh) * 2018-11-30 2020-06-09 内蒙古伊利实业集团股份有限公司 一种高活菌数乳酸菌饮料及其制备方法
CN109628346B (zh) * 2018-12-29 2022-07-12 善恩康生物科技（苏州）有限公司 发酵乳杆菌cqpc04及其在制备发酵食品中的应用
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
EP4161558A4 (de) * 2020-06-06 2024-06-19 Quorum Innovations, LLC Materialien und verfahren zur hemmung einer virusinfektion, einschliesslich einer coronavirusinfektion
US20230323332A1 (en) 2020-08-28 2023-10-12 Chr. Hansen A/S Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate
US20260009011A1 (en) * 2022-07-13 2026-01-08 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency
KR20240046081A (ko) * 2022-09-30 2024-04-08 주식회사 에이치이엠파마 락토바실러스 퍼멘텀 hem1036 균주를 유효성분으로 포함하는 암 치료 부작용 개선용 조성물
CN116590175A (zh) * 2023-04-12 2023-08-15 吉林省中科特殊食品创新研究院有限公司 一种发酵乳杆菌elf041及其应用
JP7828688B2 (ja) * 2024-02-27 2026-03-12 国立研究開発法人農業・食品産業技術総合研究機構 ブタ由来新規微生物
WO2025202427A1 (en) 2024-03-28 2025-10-02 Chr. Hansen A/S Microencapsulated microbial culture using protein-carbohydrate and chitosan complex coacervate polymer
CN119351275B (zh) * 2024-12-20 2025-04-08 云南农业大学 一株产γ-氨基丁酸的发酵粘液乳杆菌及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
CA2323340A1 (en) * 1999-10-18 2001-04-18 Armstrong World Industries, Inc. Foamed composite panel with improved acoustics and durability
CN1444484A (zh) * 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders

Also Published As

Publication number Publication date
US20060067921A1 (en) 2006-03-30
US20100074878A1 (en) 2010-03-25
CA2497989A1 (en) 2004-03-18
ES2324532T3 (es) 2009-08-10
JP2005537791A (ja) 2005-12-15
WO2004022727A1 (en) 2004-03-18
DK1539927T3 (da) 2009-07-13
EP1539927A1 (de) 2005-06-15
CN100378214C (zh) 2008-04-02
CN1701116A (zh) 2005-11-23
EP1539927B1 (de) 2009-03-18
KR20050057259A (ko) 2005-06-16
BR0314060A (pt) 2005-07-19
BRPI0314060B1 (pt) 2016-05-10
NZ538640A (en) 2007-05-31
DE60326738D1 (de) 2009-04-30
AU2003258366A1 (en) 2004-03-29
JP4455333B2 (ja) 2010-04-21
EP1539927A4 (de) 2005-09-21
CA2497989C (en) 2013-08-27
AU2002951270A0 (en) 2002-09-19
AU2003258366B2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
ATE426014T1 (de) Probiotisches bakterium: lactobacillus fermentum
ATE526836T1 (de) Nährstoffzusammensetzung mit probiotika
DK1359816T3 (da) Kombination af probiotika
DK1409645T3 (da) Probiotiske stammer af Lactobacillus salivarius
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
DE60323734D1 (de) Lactobacillus-stämme
IL160050A0 (en) Probiotic lactobacillus casei strains
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
BRPI0417825A (pt) métodos para uso de lactobacilli probióticos para animais de estimação
AU2003247193A1 (en) Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
TR200000451T2 (tr) Bağışıklık arttırıcı laktik asit bakterileri.
WO2004098622A3 (en) Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic-pituitary-adrenal axis over-activity
AR042313A1 (es) Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
DK3939602T3 (da) Stamme af Lactobacillus salivarius PS1 1610 og anvendelse deraf i forebyggelse og behandling af urogenital traktdysbiose.
PT1782818E (pt) Composição farmacêutica que compreende bacillus coagulans e simeticone para o tratamento de patologias gastrointestinais
RU2001135344A (ru) Штамм бактерий Lactobacillus rhamnosus 12L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
RU2001135347A (ru) Штамм бактерий Lactobacillus acidophilus 27L для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
TW200611973A (en) Novel microorganism strain GM-090 of lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
UA64347C2 (en) Strain of bacteria of lactobacillus acidophilus being used in the production of bacterial preparations for functional diary products
TW200500012A (en) Novel lactobacillus and use thereof
ES2169675B1 (es) Producto con propiedades antiinflamatorias para el colon humano.
MY131751A (en) Lactobacillus rhamnosus strain and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties